Search Results

There are 3548 results for: content related to: Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: Report of 2 cases

  1. Bisphosphonates and other bone agents for breast cancer

    Intervention Review

    The Cochrane Library

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD003474.pub3

  2. You have full text access to this OnlineOpen article
    Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

    Journal of Bone and Mineral Research

    Volume 23, Issue 6, June 2008, Pages: 826–836, Ana O Hoff, Béla B Toth, Kadri Altundag, Marcella M Johnson, Carla L Warneke, Mimi Hu, Ajay Nooka, Gilbert Sayegh, Valentina Guarneri, Kimberly Desrouleaux, Jeffrey Cui, Andrea Adamus, Robert F Gagel and Gabriel N Hortobagyi

    Article first published online : 4 FEB 2008, DOI: 10.1359/jbmr.080205

  3. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 10, November 2012, Pages: 788–792, S. Saracino, R. A. Canuto, M. Maggiora, M. Oraldi, M. Scoletta, L. Ciuffreda, A. M. Vandone, S. Carossa, M. Mozzati and G. Muzio

    Article first published online : 31 MAY 2012, DOI: 10.1111/j.1600-0714.2012.01173.x

  4. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 47–54, Ana O. Hoff, Bela Toth, Mimi Hu, Gabriel N. Hortobagyi and Robert F. Gagel

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05771.x

  5. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment

    Internal Medicine Journal

    Volume 39, Issue 5, May 2009, Pages: 304–316, M. Dickinson, H. M. Prince, S. Kirsa, A. Zannettino, S. D. J. Gibbs, L. Mileshkin, J. O'Grady, J. F. Seymour, J. Szer, N. Horvath and D. E. Joshua

    Article first published online : 3 NOV 2008, DOI: 10.1111/j.1445-5994.2008.01824.x

  6. You have full text access to this OnlineOpen article
    Final 5-year results of Z-FAST trial

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1192–1201, Adam M. Brufsky, W. Graydon Harker, J. Thaddeus Beck, Linda Bosserman, Charles Vogel, Christopher Seidler, Lixian Jin, Ghulam Warsi, Eliza Argonza-Aviles, John Hohneker, Solveig G. Ericson and Edith A. Perez

    Article first published online : 10 OCT 2011, DOI: 10.1002/cncr.26313

  7. Preventive oral surgery before bisphosphonate administration to reduce osteonecrosis of the jaws

    Oral Diseases

    M Mozzati, M Maggiora, M Scoletta, A Vasta, RA Canuto and G Muzio

    Article first published online : 13 JAN 2014, DOI: 10.1111/odi.12215

  8. You have full text access to this OnlineOpen article
    Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis

    Journal of Bone and Mineral Research

    Volume 27, Issue 10, October 2012, Pages: 2130–2143, J Ignacio Aguirre, Mohammed P Akhter, Donald B Kimmel, Jennifer E Pingel, Alyssa Williams, Marda Jorgensen, Lakshmyya Kesavalu and Thomas J Wronski

    Article first published online : 18 SEP 2012, DOI: 10.1002/jbmr.1669

  9. You have full text access to this OnlineOpen article
    A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

    Cancer

    Volume 113, Issue 7, 1 October 2008, Pages: 1588–1595, Pellegrino Musto, Maria Teresa Petrucci, Sara Bringhen, Tommasina Guglielmelli, Tommaso Caravita, Velia Bongarzoni, Alessandro Andriani, Giovanni D'Arena, Enrico Balleari, Giuseppe Pietrantuono, Mario Boccadoro and Antonio Palumbo

    Article first published online : 5 AUG 2008, DOI: 10.1002/cncr.23783

  10. You have full text access to this OnlineOpen article
    Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients

    British Journal of Haematology

    Volume 134, Issue 6, September 2006, Pages: 620–623, Kostas Zervas, Evgenia Verrou, Zisis Teleioudis, Konstantinos Vahtsevanos, Anastasia Banti, Dimitra Mihou, Dimitris Krikelis and Evangelos Terpos

    Article first published online : 1 AUG 2006, DOI: 10.1111/j.1365-2141.2006.06230.x

  11. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw

    Journal of Oral Pathology & Medicine

    Volume 39, Issue 5, May 2010, Pages: 390–396, Matteo Biasotto, Silvia Chiandussi, Serena Zacchigna, Silvia Moimas, Franca Dore, Gabriele Pozzato, Fabio Cavalli, Fabrizio Zanconati, Luca Contardo, Mauro Giacca and Roberto Di Lenarda

    Article first published online : 28 FEB 2010, DOI: 10.1111/j.1600-0714.2009.00878.x

  12. You have free access to this content
    Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance

    Journal of Internal Medicine

    Volume 264, Issue 4, October 2008, Pages: 315–332, S. Boonen, D. Vanderschueren, K. Venken, K. Milisen, M. Delforge and P. Haentjens

    Article first published online : 10 SEP 2008, DOI: 10.1111/j.1365-2796.2008.02010.x

  13. You have full text access to this OnlineOpen article
    ASBMR 30th Annual Meeting 1001–1300

    Journal of Bone and Mineral Research

    Volume 23, Issue S1, 13 August 2008, Pages: S2–S85,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650231302

  14. The use of bisphosphonates in cancer treatment

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 3–14, Robert Coleman

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05766.x

  15. You have full text access to this OnlineOpen article
    Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

    International Journal of Cancer

    Volume 126, Issue 2, 15 January 2010, Pages: 522–532, Penelope D. Ottewell, Diane V. Lefley, Simon S. Cross, C. Alyson Evans, Robert E. Coleman and Ingunn Holen

    Article first published online : 20 JUL 2009, DOI: 10.1002/ijc.24756

  16. You have full text access to this OnlineOpen article
    Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group

    Cancer Science

    Haruyasu Murakami, Takeharu Yamanaka, Takashi Seto, Kenji Sugio, Isamu Okamoto, Toshiyuki Sawa, Tomonori Hirashima, Koji Takeda, Shinji Atagi, Masahiro Fukuoka, Yoichi Nakanishi, Kazuhiko Nakagawa and Nobuyuki Yamamoto

    Article first published online : 12 JUL 2014, DOI: 10.1111/cas.12448

  17. You have open access to this content
    The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells

    Journal of Cellular and Molecular Medicine

    Volume 15, Issue 3, March 2011, Pages: 501–513, Hannah K. Brown, Penelope D. Ottewell, Robert E. Coleman and Ingunn Holen

    Article first published online : 8 DEC 2009, DOI: 10.1111/j.1582-4934.2009.00995.x

  18. You have full text access to this OnlineOpen article
    Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

    Cancer

    Volume 91, Issue 7, 1 April 2001, Pages: 1191–1200, James R. Berenson, Lee S. Rosen, Anthony Howell, Lester Porter, Robert E. Coleman, Walter Morley, Robert Dreicer, Steven A. Kuross, Allan Lipton and John J. Seaman

    Article first published online : 27 MAR 2001, DOI: 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0

  19. You have full text access to this OnlineOpen article
    Zoledronic Acid Treatment of 5T2MM-Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival

    Journal of Bone and Mineral Research

    Volume 18, Issue 3, March 2003, Pages: 482–492, Peter I Croucher, Hendrik De Raeve, Mark J Perry, Anja Hijzen, Claire M Shipman, Jennifer Lippitt, Jonathan Green, Eric Van Marck, Ben Van Camp and Karin Vanderkerken

    Article first published online : 1 MAR 2003, DOI: 10.1359/jbmr.2003.18.3.482

  20. You have full text access to this OnlineOpen article
    Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells

    International Journal of Cancer

    Volume 113, Issue 3, 20 January 2005, Pages: 364–371, Helen L. Neville-Webbe, Amin Rostami-Hodjegan, Catherine A. Evans, Robert E. Coleman and Ingunn Holen

    Article first published online : 28 SEP 2004, DOI: 10.1002/ijc.20602